Metlife Stock Buy Hold or Sell Recommendation
| MET Stock | USD 71.26 0.07 0.1% |
Considering the 90-day investment horizon and your above-average risk tolerance, our recommendation regarding MetLife is 'Cautious Hold'. Macroaxis provides MetLife buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding MetLife positions. The advice algorithm takes into account all of MetLife's available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting MetLife's buy or sell advice are summarized below:
Real Value 74.61 | Target Price 78.5 | Hype Value 71.11 | Market Value 71.26 | Naive Value 72.07 |
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell MetLife given historical horizon and risk tolerance towards MetLife. When Macroaxis issues a 'buy' or 'sell' recommendation for MetLife, the advice is generated through an automated system that utilizes algorithms and statistical models.
MetLife |
Execute MetLife Buy or Sell Advice
The MetLife recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on MetLife. Macroaxis does not own or have any residual interests in MetLife or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute MetLife's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Cautious Hold
Market Performance | OK | Details | |
Volatility | Very steady | Details | |
Hype Condition | Low key | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Very Low | Details | |
Economic Sensitivity | Slowly supersedes the market | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Healthy | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
MetLife Trading Alerts and Improvement Suggestions
| Over 77.0% of the company shares are owned by institutional investors | |
| On 14th of March 2024 MetLife paid $ 0.52 per share dividend to its current shareholders | |
| Latest headline from finance.yahoo.com: Dont Race Out To Buy MetLife, Inc. Just Because Its Going Ex-Dividend |
MetLife Returns Distribution Density
The distribution of MetLife's historical returns is an attempt to chart the uncertainty of MetLife's future price movements. The chart of the probability distribution of MetLife daily returns describes the distribution of returns around its average expected value. We use MetLife price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of MetLife returns is essential to provide solid investment advice for MetLife.
| Mean Return | 0.05 | Value At Risk | -1.34 | Potential Upside | 1.57 | Standard Deviation | 1.20 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of MetLife historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
MetLife Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as MetLife is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading MetLife backward and forwards among themselves. MetLife's institutional investor refers to the entity that pools money to purchase MetLife's securities or originates loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Norges Bank | 2023-12-31 | 8.4 M | Northern Trust Corp | 2023-12-31 | 7.1 M | Amvescap Plc. | 2023-12-31 | 5.8 M | Bank Of America Corp | 2023-12-31 | 5.7 M | Viking Global Investors Lp | 2023-12-31 | 5.6 M | Goldman Sachs Group Inc | 2023-12-31 | 5.6 M | Nuveen Asset Management, Llc | 2023-12-31 | 5.3 M | Legal & General Group Plc | 2023-12-31 | 5.1 M | Royal Bank Of Canada | 2023-12-31 | 5.1 M | Vanguard Group Inc | 2023-12-31 | 57.6 M | Dodge & Cox | 2023-12-31 | 53.4 M |
MetLife Cash Flow Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change In Cash | 777M | 3.2B | (513M) | 79M | 444M | 541.0M | |
| Free Cash Flow | 8.1B | 7.4B | 17.0B | 13.2B | 12.6B | 8.2B | |
| Depreciation | 630M | 619M | 694M | 673M | 718M | 502.5M | |
| Other Non Cash Items | (178M) | 749M | 745M | 5.1B | 10.0B | 5.5B | |
| Capital Expenditures | 7.1B | 5.7B | 4.3B | 4.4B | 1.2B | 1.1B | |
| Net Income | 5.9B | 5.4B | 6.6B | 2.6B | 1.6B | 1.5B | |
| End Period Cash Flow | 16.6B | 19.8B | 20.0B | 20.2B | 20.6B | 12.3B | |
| Dividends Paid | 1.8B | 1.9B | 1.8B | 1.8B | (1.8B) | (1.7B) | |
| Change To Netincome | 400M | 558M | (3.1B) | 2.4B | 2.2B | 2.3B | |
| Investments | (16.0B) | (17.4B) | (9.9B) | 1.4B | (11.0B) | (11.6B) | |
| Change Receivables | (506M) | 946M | 378M | (101M) | (116.2M) | (122.0M) | |
| Net Borrowings | 409M | 877M | (632M) | 878M | 790.2M | 829.7M |
MetLife Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to MetLife or Insurance sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that MetLife's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a MetLife stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over NYSE Composite | 0.02 | |
β | Beta against NYSE Composite | 0.21 | |
σ | Overall volatility | 0.98 | |
Ir | Information ratio | -0.03 |
MetLife Volatility Alert
MetLife has relatively low volatility with skewness of -1.8 and kurtosis of 7.05. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure MetLife's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact MetLife's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.MetLife Fundamentals Vs Peers
Comparing MetLife's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze MetLife's direct or indirect competition across all of the common fundamentals between MetLife and the related equities. This way, we can detect undervalued stocks with similar characteristics as MetLife or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of MetLife's fundamental indicators could also be used in its relative valuation, which is a method of valuing MetLife by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare MetLife to competition |
| Fundamentals | MetLife | Peer Average |
| Return On Equity | 0.0782 | -0.31 |
| Return On Asset | 0.0037 | -0.14 |
| Profit Margin | 0.04 % | (1.27) % |
| Operating Margin | 0.08 % | (5.51) % |
| Current Valuation | 63.38 B | 16.62 B |
| Shares Outstanding | 711.12 M | 571.82 M |
| Shares Owned By Insiders | 16.41 % | 10.09 % |
| Shares Owned By Institutions | 77.30 % | 39.21 % |
| Number Of Shares Shorted | 7.44 M | 4.71 M |
| Price To Earning | 28.61 X | 28.72 X |
| Price To Book | 1.69 X | 9.51 X |
| Price To Sales | 0.76 X | 11.42 X |
| Revenue | 66.41 B | 9.43 B |
| Gross Profit | 14.89 B | 27.38 B |
| EBITDA | 2.36 B | 3.9 B |
| Net Income | 1.6 B | 570.98 M |
| Cash And Equivalents | 20.2 B | 2.7 B |
| Cash Per Share | 41.28 X | 5.01 X |
| Total Debt | 18.83 B | 5.32 B |
| Debt To Equity | 4.11 % | 48.70 % |
| Current Ratio | 1.11 X | 2.16 X |
| Book Value Per Share | 39.87 X | 1.93 K |
| Cash Flow From Operations | 13.72 B | 971.22 M |
| Short Ratio | 2.63 X | 4.00 X |
| Earnings Per Share | 2.89 X | 3.12 X |
| Price To Earnings To Growth | 0.11 X | 4.89 X |
| Target Price | 85.03 | |
| Number Of Employees | 45 K | 18.84 K |
| Beta | 1.03 | -0.15 |
| Market Capitalization | 50.62 B | 19.03 B |
| Total Asset | 687.58 B | 29.47 B |
| Retained Earnings | 40.15 B | 9.33 B |
| Annual Yield | 0.03 % |
Note: Acquisition by John McCallion of 10845 shares of MetLife subject to Rule 16b-3 [view details]
MetLife Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as MetLife . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About MetLife Buy or Sell Advice
When is the right time to buy or sell MetLife? Buying financial instruments such as MetLife Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.| 2021 | 2022 | 2023 | 2024 (projected) | Short and Long Term Debt Total | 17.4B | 18.0B | 18.8B | 18.1B | Total Assets | 759.7B | 666.6B | 687.6B | 656.2B |
Use Investing Ideas to Build Portfolios
In addition to having MetLife in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Strategy ETFs Thematic Idea Now
Strategy ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Strategy ETFs theme has 1193 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Strategy ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Check out MetLife Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For more information on how to buy MetLife Stock please use our How to Invest in MetLife guide.Note that the MetLife information on this page should be used as a complementary analysis to other MetLife's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Complementary Tools for MetLife Stock analysis
When running MetLife's price analysis, check to measure MetLife's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MetLife is operating at the current time. Most of MetLife's value examination focuses on studying past and present price action to predict the probability of MetLife's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MetLife's price. Additionally, you may evaluate how the addition of MetLife to your portfolios can decrease your overall portfolio volatility.
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |
Is MetLife's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of MetLife. If investors know MetLife will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about MetLife listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 59.925 | Dividend Share 2.08 | Earnings Share 2.89 | Revenue Per Share 90.741 | Quarterly Revenue Growth 0.043 |
The market value of MetLife is measured differently than its book value, which is the value of MetLife that is recorded on the company's balance sheet. Investors also form their own opinion of MetLife's value that differs from its market value or its book value, called intrinsic value, which is MetLife's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because MetLife's market value can be influenced by many factors that don't directly affect MetLife's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between MetLife's value and its price as these two are different measures arrived at by different means. Investors typically determine if MetLife is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, MetLife's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.